Latest Cancer: Prostate news
Genomic Classifier Tests Play Heterogeneous Role in Prostate Cancer Risk Classification
posted January 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
PSMA-PET Provides Additional Risk Stratification in High-Risk Prostate Cancer
posted January 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Prebiopsy MRI Oncologically Safe for Suspected Prostate Cancer
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Fish Oil Supplementation Cuts Measure of Prostate Cancer Progression
posted December 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 
Serum 25(OH)D May Serve as Biomarker of Disease Activity in IBD Related Articles
.jpeg)
Higher Intake of Saturated, Animal Fats May Increase Mortality in Prostate Cancer 
Adverse Pathological Features Do Not Predict Benefit of Hormone Therapy in Prostate Cancer 
Focal Therapy Use Remains Uncommon in Nonmetastatic Prostate Cancer 
Risk for Prostate Cancer Elevated With Higher Ultraprocessed Food Intake Monthly Specialist Briefings
Stay Connected
